Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502895688

Cayman Chemical ntISARSCoV2 SpIke Glycopr 96
SDP

Supplier:  Cayman Chemical 50211096 WELL

Encompass_Preferred

Cayman’s Anti-SARS-CoV-2 Spike Glycoprotein RBD IgG ELISA Kit is an enzyme-linked immunosorbent assay that can be used for the qualitative assessment of the presence of antibodies against the SARS-CoV-2 spike glycoprotein RBD in human plasma and serum. In general, while PCR positivity indicates the presence of viral antigens, this serological assay indicates the presence of IgG antibodies against the SARS-CoV-2 spike glycoprotein RBD, which occurs in the weeks following SARS-CoV-2 infection. The IgG response measured in this kit does not differentiate neutralizing antibodies, which specifically interrupt the interaction between the spike glycoprotein RBD and the ACE2 receptor on the host cell, from non-neutralizing antibodies that bind to the RBD. A positive control is included in this kit to provide a cut-off for seropositivity.

Catalog No. 50-289-5688


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.